Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Description

The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.

Conditions

Brain Tumor, Recurrent, Brain Tumor, Brain Tumor, Primary, Brain Tumor - Metastatic, Brain Tumor, Adult: Glioblastoma, Brain Tumor, Adult Meningioma

Talk to us

Study Overview

On this page

Study Details

Study overview

The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.

A Multicenter Observational Study of GammaTile™ Surgically Targeted Radiation Therapy (STaRT) in Intracranial Brain Neoplasms

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Condition
Brain Tumor, Recurrent
Intervention / Treatment

-

Contacts and Locations

Phoenix

HonorHeath Scottsdale Osborn Medical Center, Phoenix, Arizona, United States, 85027

Little Rock

University of Arkansas Medical Center, Little Rock, Arkansas, United States, 72205

Castro Valley

Eden Medical Center, Castro Valley, California, United States, 94546

La Jolla

UCSD Moores Cancer Center, La Jolla, California, United States, 92093

Palm Springs

Desert Regional Medical Center, Palm Springs, California, United States, 92262

San Francisco

California Pacific Medical Center, Sutter health, San Francisco, California, United States, 94109

Denver

Centura, Denver, Colorado, United States, 80201

Englewood

Colorado Brain & Spine Institute: Swedish Campus, Englewood, Colorado, United States, 80113

Clearwater

BayCare Health, Clearwater, Florida, United States, 33756

Miami

Miami Cancer Institute, Baptist Health South Florida, Miami, Florida, United States, 33176

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Patients who undergo maximum safe resection of intracranial neoplasm(s) AND implantation of GammaTiles.
  • 2. Willing and able to provide informed consent and to participate in all evaluations.
  • 1. Inability to undergo pre-operative and post-operative imaging for disease and implant assessment.
  • 2. Major medical or psychiatric illness, which, in the investigator's opinion would prevent completion of treatment, ability to complete assessments at the time of enrollment, and/or interfere with follow ups.
  • 3. Lack of English language fluency sufficient to allow for completion of neurocognitive and QOL tests (which are in English).

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

GT Medical Technologies, Inc.,

Michael A. Garcia, MD, MS, STUDY_DIRECTOR, GT Medical Technologies

Study Record Dates

2028-12-31